Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]
News [4283]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid...
Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017
Neratinib in HER2 or HER3 mutant solid tumours
Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Neratinib in HER2 or HER3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017
Surgical and social perspectives on nipple sparing mastectomy
Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy
Surgical and social perspectives on nipple sparing mastectomy ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )
24 Mar 2017
Mechanisms of resistance in triple negative breast cancer
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Mechanisms of resistance in triple negative breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
24 Mar 2017
Cyclin dependent kinases to treat metastatic breast cancer
Dr Sibylle Loibl - German Breast Group
Cyclin dependent kinases to treat metastatic breast cancer ( Dr Sibylle Loibl - German Breast Group )
24 Mar 2017
De-escalating and escalating surgery in the management of early breast cancer
Dr Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA
De-escalating and escalating surgery in the management of early breast cancer ( Dr Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA )
24 Mar 2017
Personalising breast cancer therapies
Dr Philip Poortmans - Institut Curie, Paris, France
Personalising breast cancer therapies ( Dr Philip Poortmans - Institut Curie, Paris, France )
23 Mar 2017
CDK 4/6 inhibitors for metastatic breast cancer
Dr Giuseppe Curigliano, Dr Carmen Criscitiello, Dr Ghadeer Shubassi, Prof...
CDK 4/6 inhibitors for metastatic breast cancer ( Dr Giuseppe Curigliano, Dr Carmen Criscitiello, Dr Ghadeer Shubassi, Prof Pierfranco Conte )
20 Mar 2017
Next steps for treating breast cancer
Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA
Next steps for treating breast cancer ( Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA )
6 Jan 2017
Conference goals and cancer care in Brazil
Dr Carla Ismael - Presidente Sociedad Franco Brasilera de Oncología, Brasil
Conference goals and cancer care in Brazil ( Dr Carla Ismael - Presidente Sociedad Franco Brasilera de Oncología, Brasil )
21 Dec 2016
Biomarker driven clinical trials
Dr Oleg Gluz - West German Study Group Monchengladbach, Germany
Biomarker driven clinical trials ( Dr Oleg Gluz - West German Study Group Monchengladbach, Germany )
20 Dec 2016
A phase III study of buparlisib and fulvestrant in HR positive advanced breast...
Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation